Hello, Fool! | Login | Signup | My Fool
Sep 5, 2008 6:59 AM ET | Site Changes | Help
A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.
View All Commentary (EBS)
Recs
synergize (98.02) Submitted: 7/15/08 12:13 AM : Start Price: $12.19 EBS Score: 2.03
Small Cap Growth company with high PE growth grade.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK